Interstitial and orphan lung disease

Interstitial and orphan lung disease

No relevant pharmacokinetic drug–drug interaction between nintedanib and pirfenidone
Luca Richeldi, Sophie Fletcher, Huzaifa Adamali, Nazia Chaudhuri, Sabrina Wiebe, Sven Wind, Kathrin Hohl, Andrew Baker, Rozsa Schlenker-Herceg, Susanne Stowasser, Toby M. Maher

European Respiratory Journal Jan 2019, 53 (1) 1801060; DOI: 10.1183/13993003.01060-2018
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Joseph Jacob, Nikhil Hirani, Coline H.M. van Moorsel, Srinivasan Rajagopalan, John T. Murchison, Hendrik W. van Es, Brian J. Bartholmai, Frouke T. van Beek, Marjolijn H.L. Struik, Gareth A. Stewart, Maria Kokosi, Ryoko Egashira, Anne Laure Brun, Gary Cross, Joseph Barnett, Anand Devaraj, George Margaritopoulos, Ronald Karwoski, Elisabetta Renzoni, Toby M. Maher, Athol U. Wells

European Respiratory Journal Jan 2019, 53 (1) 1800869; DOI: 10.1183/13993003.00869-2018
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)
Ganesh Raghu, Luca Richeldi, Bruno Crestani, Peter Wung, Raphael Bejuit, Corinne Esperet, Christian Antoni, Christina Soubrane

European Respiratory Journal Dec 2018, 52 (6) 1801130; DOI: 10.1183/13993003.01130-2018
Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study
Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström

European Respiratory Journal Dec 2018, 52 (6) 1801278; DOI: 10.1183/13993003.01278-2018
Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis
Grazyna Kwapiszewska, Anna Gungl, Jochen Wilhelm, Leigh M. Marsh, Helene Thekkekara Puthenparampil, Katharina Sinn, Miroslava Didiasova, Walter Klepetko, Djuro Kosanovic, Ralph T. Schermuly, Lukasz Wujak, Benjamin Weiss, Liliana Schaefer, Marc Schneider, Michael Kreuter, Andrea Olschewski, Werner Seeger, Horst Olschewski, Malgorzata Wygrecka

European Respiratory Journal Nov 2018, 52 (5) 1800564; DOI: 10.1183/13993003.00564-2018
Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI
Na Sun, Isis E. Fernandez, Mian Wei, Michael Witting, Michaela Aichler, Annette Feuchtinger, Gerald Burgstaller, Stijn E. Verleden, Philippe Schmitt-Kopplin, Oliver Eickelberg, Axel Walch

European Respiratory Journal Sep 2018, 52 (3) 1702314; DOI: 10.1183/13993003.02314-2017
Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome
Olivier Brugière, Antoine Roux, Jerome Le Pavec, Deborah Sroussi, François Parquin, Pauline Pradère, Clairelyne Dupin, Vincent Bunel, Gisele Mourin, Gilles Jebrak, Gaëlle Dauriat, Yves Castier, Pierre Mordant, Brice Lortat-Jacob, Sylvain Jean-Baptiste, Herve Mal, Caroline Suberbielle, Chantal Gautreau, Sophie Caillat-Zucman, Aurélie Cazes, Gabriel Thabut, Jean-Luc Taupin

European Respiratory Journal Aug 2018, 52 (2) 1701898; DOI: 10.1183/13993003.01898-2017
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis
Margaret L. Salisbury, Barry H. Gross, Aamer Chughtai, Mohamed Sayyouh, Ella A. Kazerooni, Brian J. Bartholmai, Meng Xia, Susan Murray, Jeffrey L. Myers, Amir Lagstein, Kristine E. Konopka, Elizabeth A. Belloli, Jamie S. Sheth, Eric S. White, Colin Holtze, Fernando J. Martinez, Kevin R. Flaherty

European Respiratory Journal Aug 2018, 52 (2) 1800443; DOI: 10.1183/13993003.00443-2018
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis
Kevin R. Flaherty, Martin Kolb, Carlo Vancheri, Wenbo Tang, Craig S. Conoscenti, Luca Richeldi

European Respiratory Journal Aug 2018, 52 (2) 1702593; DOI: 10.1183/13993003.02593-2017
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus, Marlies Wijsenbeek

European Respiratory Journal Aug 2018, 52 (2) 1800230; DOI: 10.1183/13993003.00230-2018

Main menu

User menu

Search

Interstitial and orphan lung disease

Pages